Infinity Pharmaceuticals, Inc.
INFIQ · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $38 | $81 | $29 | $22 |
| Short-Term Investments | $0 | $0 | $6 | $20 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $2 | $2 | $2 | $2 |
| Total Curr. Assets | $40 | $82 | $36 | $45 |
| Property Plant & Equip (Net) | $1 | $2 | $3 | $4 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $2 | $3 | $3 | $4 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $42 | $85 | $39 | $49 |
| Liabilities | – | – | – | – |
| Payables | $4 | $2 | $3 | $2 |
| Short-Term Debt | $1 | $1 | $1 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $9 | $6 | $7 |
| Other Curr. Liab. | $9 | $0 | $1 | $1 |
| Total Curr. Liab. | $14 | $13 | $11 | $10 |
| LT Debt | $48 | $50 | $23 | $32 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $28 | $0 |
| Total NC Liab. | $48 | $50 | $51 | $32 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $1 | $1 | $2 | $2 |
| Total Liabilities | $61 | $63 | $62 | $41 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$856 | -$812 | -$766 | -$726 |
| AOCI | $0 | $0 | -$0 | $0 |
| Other Equity | $837 | $833 | $743 | $733 |
| Total Equity | -$19 | $22 | -$23 | $8 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $42 | $85 | $39 | $49 |
| Net Debt | $10 | -$30 | -$4 | $10 |